Esophagus to Small Intestine

Am J Gastroenterol. 2024;119(6):1066–73

Lim AHW, Ngoi B, Perkins GB, Wong S, Whitelock G, Hurtado P, Ruszkiewicz A, Le TA, Hissaria P, Nguyen NQ

Outcomes of serum food-specific immunoglobulin G4 to guide elimination diet in patients with eosinophilic esophagitis


Introduction: Eosinophilic esophagitis (EoE) is associated with atopy; however, recent studies have identified an association with food-specific immunoglobulin G4 (FS-IgG4) rather than immunoglobulin E antibodies. This study aimed to evaluate the role of serum FS-IgG4 in guiding an elimination diet and its outcomes.
Methods: Patients with and without EoE were enrolled in a prospective, controlled, single tertiary center trial. Serum FS-IgG4 titers, esophageal eosinophil counts, and dysphagia symptom questionnaire scores were assessed, and participants with elevated FS-IgG4 (cutoff of 10 mgA/L) commenced 6-week targeted elimination diet. Repeat serum FS-IgG4 and endoscopic and histologic examination were performed at 6-week follow-up.
Results: 22 patients with active EoE and 13 controls were recruited. Serum FS-IgG4 to milk, wheat, soy, eggs, and nuts was significantly higher in EoE (p = 0.0002, p = 0.002, p = 0.003, p = 0.012, and p < 0.001, respectively). Elevated serum FS-IgG4 to 1 or more food groups (median 2) was identified in 21 of 22 patients (95.4%) with EoE; 20 of 21 underwent 6-week dietary elimination. Median reductions in Dysphagia Symptom Questionnaire score and Eosinophilic Esophagitis Endoscopic Reference Score after elimination were 8 (p = 0.0007) and 1 (p = 0.002), respectively. Nine patients (45%) had histological remission (< 15 eosinophils per high-power field). Fall in median esophageal eosinophil count was not statistically significant (50 vs. 23; p = 0.068). Serum FS-IgG4 did not decline by 6-week follow-up.

Discussion: Serum food-specific immunoglobulin G4 (FS-IgG4) to milk, wheat, soy, egg, and nuts was present at higher levels in eosinophilic esophagitis (EoE), with targeted elimination resulting in 45% histologic remission rate. Serum FS-IgG4 has potential as a non-invasive biomarker in EoE. When successful, FS-IgG4-led elimination diet can negate need for medications and be viewed more favorably by patients because of its smaller endoscopic burden compared with empirical elimination diets.

N.Q. Nguyen, Department of Gastroenterology and Hepatology, Royal Adelaide Hospital, Adelaide, SA, Australia, E-Mail: quocnam.nguyen@sa.gov.au

DOI: 10.14309/ajg.0000000000002678

Back to overview

this could be of interest:

More articles on the topic